“KLOW” – BPC-157/TB-500/GHK-Cu/KPV

KLOW is a four-component peptide blend containing BPC-157, TB-500, GHK-Cu, and KPV. BPC-157 (10mg) is a pentadecapeptide originally identified as a partial sequence of a protein found in human gastric juice. TB-500 (10mg) is a synthetic version of a 43-amino-acid segment of thymosin beta-4. GHK-Cu (50mg) is the tripeptide glycyl-L-histidyl-L-lysine bound to a copper(II) ion, first isolated from human plasma in 1973 by Dr. Loren Pickart. KPV (10mg) is a tripeptide of lysine, proline, and valine, derived from the C-terminal end of alpha-MSH.

KPV is the newest addition relative to the other three peptides and has its own distinct research angle: it has been studied in animal models of intestinal inflammation for its ability to reduce inflammatory cytokine activity without the immunosuppressive trade-offs of some anti-inflammatory compounds, working independently of the melanocortin receptor pathway that alpha-MSH itself uses. Combined with BPC-157’s gut and tissue-repair research, TB-500’s actin-related cell migration research, and GHK-Cu’s collagen and remodeling research, the four peptides cover distinct but complementary mechanisms, though again, the specific four-peptide blend has not itself been evaluated in a published study.

The blend totals 80mg of lyophilized peptide powder, appears white to off-white with a slight blue tint from the copper content, is water-soluble, and should be stored refrigerated at 2–8°C. This product is strictly for research purposes only.

Key Characteristics

component weights, total 80mg, storage

Why KPV Is Added to This Blend

KPV’s research distinguishes it from the other three peptides: rather than tissue structural repair, its studied mechanism is anti-inflammatory, specifically in gut and intestinal inflammation models, working through a melanocortin-receptor-independent pathway. Researchers studying inflammation alongside tissue repair sometimes look at KPV as a complementary angle to BPC-157’s gut-healing research, though as with the rest of this blend, the combination hasn’t been tested as a single unit in published literature.

Frequently Asked Questions :

What does KPV add to this blend?

Studied independently for anti-inflammatory effects, particularly in intestinal inflammation models, complementing the tissue-repair focus of the other three peptides.

Is the four-peptide blend studied as a whole?

No, each peptide has independent research; the combination itself hasn’t been evaluated in a published study.

How is KLOW different from GLOW?

KLOW adds KPV and uses higher peptide weights (80mg total vs. 50mg), while GLOW is the three-peptide version without KPV.

How should it be reconstituted and stored?

Bacteriostatic water, refrigerate 2–8°C.

Where can I buy KLOW for research?

Sold as an 80mg kit, HPLC/MS verified.